BlackRock’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.4M Sell
2,641,268
-118,702
-4% -$1.54M ﹤0.01% 2655
2025
Q1
$29.2M Sell
2,759,970
-229,631
-8% -$2.43M ﹤0.01% 2687
2024
Q4
$50.7M Buy
2,989,601
+37,588
+1% +$638K ﹤0.01% 2415
2024
Q3
$68.5M Buy
2,952,013
+302,175
+11% +$7.01M ﹤0.01% 2263
2024
Q2
$64.5M Sell
2,649,838
-93,164
-3% -$2.27M ﹤0.01% 2243
2024
Q1
$92.6M Buy
2,743,002
+344,706
+14% +$11.6M ﹤0.01% 2066
2023
Q4
$75.6M Buy
2,398,296
+260,596
+12% +$8.22M ﹤0.01% 2208
2023
Q3
$54.6M Buy
2,137,700
+145,465
+7% +$3.72M ﹤0.01% 2320
2023
Q2
$57.1M Buy
1,992,235
+195,918
+11% +$5.62M ﹤0.01% 2357
2023
Q1
$43.1M Sell
1,796,317
-88,568
-5% -$2.12M ﹤0.01% 2509
2022
Q4
$32M Sell
1,884,885
-75,704
-4% -$1.28M ﹤0.01% 2728
2022
Q3
$29.1M Buy
1,960,589
+56,287
+3% +$834K ﹤0.01% 2790
2022
Q2
$30M Buy
1,904,302
+208,663
+12% +$3.28M ﹤0.01% 2802
2022
Q1
$45.7M Sell
1,695,639
-63,951
-4% -$1.72M ﹤0.01% 2600
2021
Q4
$65.1M Buy
1,759,590
+38,882
+2% +$1.44M ﹤0.01% 2451
2021
Q3
$82.2M Buy
1,720,708
+17,199
+1% +$822K ﹤0.01% 2310
2021
Q2
$57.6M Sell
1,703,509
-49,095
-3% -$1.66M ﹤0.01% 2567
2021
Q1
$72.4M Sell
1,752,604
-29,351
-2% -$1.21M ﹤0.01% 2355
2020
Q4
$77.3M Buy
1,781,955
+619,727
+53% +$26.9M ﹤0.01% 2197
2020
Q3
$49.9M Buy
1,162,228
+198,866
+21% +$8.53M ﹤0.01% 2257
2020
Q2
$45M Buy
963,362
+887,938
+1,177% +$41.5M ﹤0.01% 2287
2020
Q1
$1.03M Buy
75,424
+12,330
+20% +$168K ﹤0.01% 3789
2019
Q4
$686K Buy
63,094
+544
+0.9% +$5.92K ﹤0.01% 4041
2019
Q3
$643K Buy
62,550
+39,002
+166% +$401K ﹤0.01% 4055
2019
Q2
$222K Buy
23,548
+4,480
+23% +$42.2K ﹤0.01% 4289
2019
Q1
$130K Sell
19,068
-1,302
-6% -$8.88K ﹤0.01% 4284
2018
Q4
$92K Sell
20,370
-372
-2% -$1.68K ﹤0.01% 4323
2018
Q3
$183K Buy
20,742
+837
+4% +$7.39K ﹤0.01% 4270
2018
Q2
$169K Buy
+19,905
New +$169K ﹤0.01% 4293